- Home
- Clinical Resources Search
- PQI: Use of Rucaparib (Rubraca®) and Indications
Use of Rucaparib (Rubraca®) and Indications
About this PQI
The purpose of this PQI is to discuss the various indications and management of rucaparib (Rubraca®).
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 10/14/2025
PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia
Last Updated: 10/07/2025
PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events
Last Updated: 10/07/2025
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Last Updated: 09/19/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 11/16/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 11/16/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 11/16/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 11/16/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Avutometinib and Defactinib
Last Updated: 10/27/2025
Cisplatin and Etoposide
Last Updated: 10/25/2025
Mirvetuximab Soravtansine
Last Updated: 06/19/2023
Trastuzumab
Last Updated: 05/10/2022
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Avutometinib and Defactinib
Last Updated: 10/27/2025
Cisplatin and Etoposide
Last Updated: 10/25/2025
Carboplatin and Etoposide
Last Updated: 10/25/2025
Mirvetuximab Soravtansine
Last Updated: 06/19/2023
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Avutometinib and Defactinib
Last Updated: 10/27/2025
Cisplatin and Etoposide
Last Updated: 10/25/2025
Mirvetuximab Soravtansine
Last Updated: 06/19/2023
Trastuzumab
Last Updated: 05/10/2022
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Carboplatin and Etoposide
Last Updated: 10/25/2025
Talazoparib
Last Updated: 09/30/2024
Rucaparib
Last Updated: 09/30/2024
Relugolix
Last Updated: 05/10/2023
Patient Education Sheet
PQI
PQI in Action
Rucaparib
Last Updated: 09/30/2024
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 09/06/2023
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 11/01/2019
Patient Education Sheet
PQI
PQI in Action
Rucaparib
Last Updated: 09/30/2024
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 09/06/2023
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 11/01/2019
PQI Podcast
Patient Education Sheet
Patient Education Sheet
PQI
S9 E11: Honoring Veterans Through Early Cancer Detection
Last Updated: 11/11/2025
Amivantamab and Lazertinib
Last Updated: 11/03/2025
Lenvatinib and Pembrolizumab
Last Updated: 11/03/2025
PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia
Last Updated: 10/07/2025






